DK0813411T3 - Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein - Google Patents

Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein

Info

Publication number
DK0813411T3
DK0813411T3 DK96901960T DK96901960T DK0813411T3 DK 0813411 T3 DK0813411 T3 DK 0813411T3 DK 96901960 T DK96901960 T DK 96901960T DK 96901960 T DK96901960 T DK 96901960T DK 0813411 T3 DK0813411 T3 DK 0813411T3
Authority
DK
Denmark
Prior art keywords
pct
optionally substituted
secretion
date
vincopetine
Prior art date
Application number
DK96901960T
Other languages
Danish (da)
English (en)
Inventor
Mitsuru Kakihana
Takuo Kosaka
Akinobu Nagaoka
Giichi Goto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0813411T3 publication Critical patent/DK0813411T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96901960T 1995-02-15 1996-02-08 Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein DK0813411T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2668795 1995-02-15
PCT/JP1996/000265 WO1996025161A1 (en) 1995-02-15 1996-02-08 Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein

Publications (1)

Publication Number Publication Date
DK0813411T3 true DK0813411T3 (da) 2002-05-13

Family

ID=12200316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96901960T DK0813411T3 (da) 1995-02-15 1996-02-08 Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein

Country Status (11)

Country Link
US (1) US5965568A (de)
EP (1) EP0813411B1 (de)
AT (1) ATE212227T1 (de)
AU (1) AU4632996A (de)
CA (1) CA2213094A1 (de)
DE (1) DE69618765T2 (de)
DK (1) DK0813411T3 (de)
ES (1) ES2171646T3 (de)
HU (1) HUP9801155A3 (de)
PT (1) PT813411E (de)
WO (1) WO1996025161A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024392A1 (fr) * 1998-10-26 2000-05-04 Sumitomo Pharmaceuticals Company, Limited Inhibiteur de la formation de beta-amyloide
US8153646B2 (en) * 2000-08-10 2012-04-10 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
ATE526020T1 (de) * 2000-08-10 2011-10-15 Cold Spring Harbor Lab Gesteigertes kognitives training
WO2004047854A2 (en) * 2002-11-22 2004-06-10 Novartis Ag Methods for the treatment of alzheimers disease and compositions therefore
EP1679059A4 (de) * 2003-10-28 2009-11-04 Univ Mexico Nacional Autonoma Verwendung von vinpocetin zur vermeidung von komplikationen, insbesondere im zusammenhang mit dem gehör, die bei epilepsie auftreten, und ihre behandlung
GB0329498D0 (en) 2003-12-19 2004-01-28 Novartis Ag Organic compounds
CZ2006628A3 (cs) * 2004-03-12 2007-01-24 Egis Gyogyszergyár Nyrt. Kombinovaná farmaceutická kompozice pro inhibici poklesu kognitivních funkcí
JP5160764B2 (ja) 2006-10-13 2013-03-13 全薬工業株式会社 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤
KR101095026B1 (ko) * 2009-01-23 2011-12-20 한국과학기술연구원 비스(스티릴)피리미딘 및 비스(스티릴)벤젠 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 베타아밀로이드 집적 관련 질환의 예방 또는 치료용 약학적 조성물
WO2010103539A2 (en) 2009-03-09 2010-09-16 Dinesh Shantilal Patel Sustained release oral formulation of vinpocetine
CN102875547B (zh) * 2011-07-15 2015-05-27 海南灵康制药有限公司 一种长春西汀化合物及其制法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035370A (en) * 1971-11-03 1977-07-12 Richter Gedeon Vegyeszeti Gyar Rt. Alkaloid esters
HU181941B (en) * 1979-11-23 1983-11-28 Richter Gedeon Vegyeszet Process for producing apovincaminic acid ester derivatives
HU201674B (en) * 1987-08-26 1990-12-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
JPH02152979A (ja) * 1988-12-06 1990-06-12 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
JPH02204488A (ja) * 1989-02-03 1990-08-14 Taisho Pharmaceut Co Ltd エブルナメニン誘導体
JP3053913B2 (ja) * 1991-07-15 2000-06-19 帝三製薬株式会社 ビンポセチン類含有貼付剤
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
EP0683234B2 (de) * 1993-01-25 2007-06-06 Takeda Chemical Industries, Ltd. Antikörper gegen beta-amyloid oder derivative davon und seine verwendung

Also Published As

Publication number Publication date
ATE212227T1 (de) 2002-02-15
WO1996025161A1 (en) 1996-08-22
HUP9801155A3 (en) 1999-03-01
DE69618765T2 (de) 2002-10-17
AU4632996A (en) 1996-09-04
HUP9801155A2 (hu) 1998-09-28
PT813411E (pt) 2002-07-31
EP0813411A1 (de) 1997-12-29
US5965568A (en) 1999-10-12
ES2171646T3 (es) 2002-09-16
EP0813411B1 (de) 2002-01-23
CA2213094A1 (en) 1996-08-22
DE69618765D1 (de) 2002-03-14

Similar Documents

Publication Publication Date Title
MX9804107A (es) Derivados de quinolina.
EP0040639A4 (de) Isoxazol-derivate.
GB1495526A (en) Chroman derivatives
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
EP0703222A4 (de) 3-aminoazepin-verbindung und ihre pharmazeutische verwendung
DK0813411T3 (da) Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein
IL107869A0 (en) Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
IL113778A (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
SE8301412D0 (sv) Substituerade 1h-pyrazolo(1,5)pyrimidiner och forfarande for deras framstellning
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
FI951555A0 (fi) 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
EP0945426A4 (de) Nitronderivate
DE69719974D1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
TR199900096T2 (xx) Bradykinin B2 antagonistleri olarak elveri�li N-benzensulfonil-L-prolin t�revleri.
HUP9904594A2 (hu) Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO955328D0 (no) Pyridazin-derivater
MX9600816A (es) Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
RU95110868A (ru) Новые конденсированные производные тиазола, способ его получения и его фармацевтическая композиция
HUP0000783A2 (hu) N-(piridinil-amino)-izoindolinok és származékaik, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK614989A (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
DK356287A (da) 2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DE3773223D1 (de) In stellung 2 substituierte monoaryl-5 as-triazinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.